AC Immune (ACIU) Cash from Operations Growth (5y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.18% |
| Sep 30, 2025 | -6.63% |
| Jun 30, 2025 | -4.87% |
| Mar 31, 2025 | -16.54% |
| Dec 31, 2024 | 20.36% |
| Sep 30, 2024 | -24.12% |
| Jun 30, 2024 | 49.17% |
| Mar 31, 2024 | -55.37% |
| Dec 31, 2023 | -9.91% |
| Sep 30, 2023 | -4.85% |
| Jun 30, 2023 | -16.84% |
| Mar 31, 2023 | -5.24% |
| Dec 31, 2022 | -14.88% |
| Sep 30, 2022 | 78.36% |
| Jun 30, 2022 | -17.18% |
| Mar 31, 2022 | -16.17% |
| Dec 31, 2021 | -21.86% |
| Sep 30, 2021 | -30.60% |
| Jun 30, 2021 | -106.22% |
| Mar 31, 2021 | -19.90% |
| Dec 31, 2020 | -30.25% |